T2 Biosystems, Inc. TTOO shares traded lower Tuesday as the stock pulled back following Monday's strength after the FDA cleared the company's biothreat panel for commercial distribution.
What To Know: Shares of T2 Biosystems received a boost Monday following the FDA clearance which will allow the company to immediately start marketing and selling the T2Biothreat Panel, a direct-from-blood molecular diagnostic test, in the U.S. market.
However, T2 Biosystems stock pulled back Tuesday by over 26% following Monday's gain.
Related Link: What's Going On With Intel Stock?
TTOO Price Action: Shares of TTOO were gaining back 5.3% to trade at 39 cents in the after-hours session, according to Benzinga Pro.
Image by MasterTux from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
